Strategic Market Access
Rotterdam, The Netherlands
Rosemary Jose is a Director in the Rotterdam office, the Netherlands. Rosemary works within the Strategic Market Access (SMA) Center of Excellence. Her main expertise is in payer value communication, conducting payer/HTA landscape assessments, providing market access insights into clinical trials and observational studies, developing value dossiers and objection handlers, coordinating market access strategic workshops for country affiliates, publishing real-world evidence, and facilitating the development of health economic models.
She has >12 years’ experience across the pharmaceutical industry, including 10 years in market access and health economics, both in global and consulting roles – leading strategic deliverables, managing international clients and mentoring multi-cultural teams. She has also provided on-site support to pharmaceutical clients in Europe, driving the market access strategy through cross-functional collaboration, to facilitate reimbursement. Her experience covers multiple therapeutic areas including oncology, neurosciences, ophthalmology, infections and immunology, gastroenterology and cardiovascular medicine. Rosemary holds a PhD in Pharmacogenetics from JIPMER, India, a Certification in HTA and Market Access from the Galbraith Wight Business School, the UK., and a Postgraduate Certificate in Health Economics from the University of Aberdeen, the UK.